Sandbox:Ifeoma Anaya: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) No edit summary |
Sara Mohsin (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
!classification | !style="background:#4479BA; color: #FFFFFF;" align="center" + |classification | ||
! | !style="background:#4479BA; color: #FFFFFF;" align="center" + | | ||
! | !style="background:#4479BA; color: #FFFFFF;" align="center" + | | ||
! | !style="background:#4479BA; color: #FFFFFF;" align="center" + | | ||
|- | |- | ||
|SCC | |SCC | ||
Revision as of 18:31, 28 August 2020
| classification | |||
|---|---|---|---|
| SCC | |||
| BCC | |||
| Melanoma |
Practice here
| Criteria | Symptomatic WM | Asymptomatic WM | IgM-Related Disorders | MGUS |
|---|---|---|---|---|
| IgM monoclonal protein | + | + | + | + |
| Bone marrow infiltration | + | + | - | - |
| Symptoms attributable to IgM | + | - | + | - |
| Symptoms attributable to tumor infiltration | + | - | - | - |
References
- ↑ Kiran U, Aggarwal S, Choudhary A, Uma B, Kapoor PM (2017). "The blalock and taussig shunt revisited". Ann Card Anaesth. 20 (3): 323–330. doi:10.4103/aca.ACA_80_17. PMC 5535574. PMID 28701598.